Metastatic Castration-resistant Prostate Cancer — Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC
Citation(s)
PDL-1 Inhibition With Avelumab and Concurrent Second-generation ADT in African Americans With Castrate-resistant Metastatic Prostate Cancer